| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.16 | 9e-05 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |